疾病模型中人脑类淋巴动力学的无创研究
前瞻性纳入可逆性脑血管收缩综合征伴血脑屏障破坏(3-T CE-T2-FLAIR 示动脉旁钆渗漏)患者,行动态增强 MRI 观察类淋巴动力学。11 例中示踪剂呈离心性转运,于给药后 961–1086 分钟完全清除;不同颅内区域强化起始时间不一。
要点
- 动脉旁类淋巴钆渗漏在 CE-T2-FLAIR 上于 9 分钟即出现早期信号增高。
- 示踪剂强化速率在 9–18 分钟后升高、45–54 分钟后降低,给药后 961–1086 分钟完全清除。
- 示踪剂呈离心性清除至大脑凸面,可能朝向类淋巴-脑膜淋巴管出口。
核心结论
- 在血脑屏障破坏的人体模型中,外源性钆对比剂渗入动脉旁类淋巴系统后约 961–1086 分钟完全清除,强化始于不同颅内区域但最终呈离心性清除至大脑凸面。
研究设计与样本
- 前瞻性研究,纳入 11 例表现为血脑屏障破坏(3-T 三维各向同性 CE-T2-FLAIR 示动脉旁钆渗漏)的可逆性脑血管收缩综合征患者;静脉注射钆基对比剂后连续 5–6 次 9 分钟 CE-T2-FLAIR(早期组)及一次非增强 T2-FLAIR 延迟扫描(延迟组)。
关键影像表现/征象
- 校准信号强度在神经周围间隙(颅神经 V,p=0.008;颅神经 VII+VIII,p=0.003)、脉络丛(p=0.003)、白质(p=0.004)和矢状旁硬脑膜(p=0.004)于 9 分钟出现早期增高。
- 体积、平均浓度指数和 median 浓度指数在 9–18 分钟后强化速率升高,45–54 分钟后强化速率降低。
- 钆基对比剂呈离心性转运,给药后 961–1086 分钟内完全清除。
诊断标准与关键数值
- 以 3-T 三维各向同性 CE-T2-FLAIR 上动脉旁钆渗漏定义血脑屏障破坏。
- 校准信号强度于给药后 9 分钟在颅神经 V(p=0.008)、颅神经 VII+VIII(p=0.003)、脉络丛(p=0.003)、白质(p=0.004)和矢状旁硬脑膜(p=0.004)增高。
- 体积、平均浓度指数和 median 浓度指数在 9–18 分钟后强化速率升高,45–54 分钟后强化速率降低。
临床应用与阅片要点
- 动态 CE-T2-FLAIR 可无创显示类淋巴示踪剂的早期强化和离心性清除过程。
- 类淋巴清除时间间隔和离心方向可能对近期临床类淋巴评估有启示。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To explore human glymphatic dynamics in a diseased model via a noninvasive technique.
METHODS: Patients with reversible vasoconstriction syndrome (RCVS) presenting with blood-brain barrier disruption, i.e., para-arterial gadolinium leakage on 3-T 3-dimensional isotropic contrast-enhanced T2-fluid-attenuated inversion recovery (CE-T2-FLAIR) magnetic resonance imaging (MRI), were prospectively enrolled. Consecutive 9-min-CE-T2-FLAIR for 5-6 times (early panel) after intravenous gadolinium-based contrast agent (GBCA) administration and one time-varying deferred scan of noncontrast T2-FLAIR (delayed panel) were performed. In Bundle 1, we measured the calibrated signal intensities (cSIs) of 10 different anatomical locations. In Bundle 2, brain-wide measurements of para-arterial glymphatic volumes, means, and medians of the signal intensities were conducted. We defined mean (mCoIs) or median (mnCoIs) concentration indices as products of volumes and signal intensities.
RESULTS: Eleven subjects were analyzed. The cSIs demonstrated early increase (9 min) in perineural spaces: (cranial nerve [CN] V, p = 0.008; CN VII + VII, p = 0.003), choroid plexus (p = 0.003), white matter (p = 0.004) and parasagittal dura (p = 0.004). The volumes, mCoIs, and mnCoIs demonstrated increasing rates of enhancement after 9 to 18 min and decreasing rates after 45 to 54 min. The GBCA was transported centrifugally and completely removed within 961-1086 min after administration.
CONCLUSIONS: The exogenous GBCA leaked into the para-arterial glymphatics could be completely cleared around 961 to 1086 min after administration in a human model of BBB disruption. The tracer enhancement started variously in different intracranial regions but was eventually cleared centrifugally to brain convexity, probably towards glymphatic-meningeal lymphatics exits.
CLINICAL RELEVANCE STATEMENT: Glymphatic clearance time intervals and the centrifugal directions assessed by a noninvasive approach may have implications for clinical glymphatic evaluation in the near future.
KEY POINTS: • This study aimed to investigate the human glymphatic dynamics in a noninvasive diseased model. • The intracranial MR-detectable gadolinium-based contrast agents were removed centrifugally within 961 to 1086 min. • The glymphatic dynamics was demonstrable by enhancing MRI in an in vivo diseased model noninvasively.
引用
- Wu, Kuo, Chang, et al. Noninvasive investigations of human glymphatic dynamics in a diseased model. Eur Radiol. 2023. PMID: 37402004. doi:10.1007/s00330-023-09894-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。